Provided by Tiger Trade Technology Pte. Ltd.

FibroBiologics

1.73
-0.0300-1.70%
Post-market: 1.760.0300+1.73%18:10 EDT
Volume:83.74K
Turnover:143.58K
Market Cap:11.52M
PE:-0.36
High:1.80
Open:1.73
Low:1.67
Close:1.76
52wk High:12.40
52wk Low:0.6201
Shares:6.66M
Float Shares:5.84M
Volume Ratio:0.28
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7656
EPS(LYR):-8.3501
ROE:-660.08%
ROA:-95.77%
PB:2.48
PE(LYR):-0.21

Loading ...

FibroBiologics presents preclinical thymus organoid data targeting age-related immune decline

Reuters
·
Apr 10

BRIEF-Fibrobiologics Inc - Enters Lease Termination Agreement With United Fire & Casualty On April 3, 2026 - SEC Filing

Reuters
·
Apr 10

FibroBiologics amends 8-K to add omitted item on sublease termination

Reuters
·
Apr 10

FibroBiologics Ends Texas Sublease, Consolidates Houston Operations

TIPRANKS
·
Apr 10

FibroBiologics relocates principal executive offices to Houston, Texas

Reuters
·
Apr 10

FibroBiologics Implements One-for-Twenty Reverse Stock Split

TIPRANKS
·
Apr 04

FibroBiologics closes $3 million public offering of common stock, warrants

Reuters
·
Apr 03

FibroBiologics Announces Closing of $3 Million Public Offering

GlobeNewswire
·
Apr 03

FibroBiologics prices $3M public offering

TIPRANKS
·
Apr 01

FibroBiologics Announces Pricing of $3 Million Public Offering

GlobeNewswire
·
Apr 01

FibroBiologics manufactures first batch of CYWC628 drug product for trials

TIPRANKS
·
Apr 01

Fibrobiologics Inc - Plans Phase 1/2 Clinical Trial of Cywc628 in Dfu Patients in H1 2026

THOMSON REUTERS
·
Apr 01

Fibrobiologics Inc - Cywc628 Manufactured Under FDA Cgmp, Pending Safety and Quality Testing

THOMSON REUTERS
·
Apr 01

FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial

GlobeNewswire
·
Apr 01

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:59 PM

Reuters
·
Mar 28

Fibrobiologics Inc trading halted, news pending

TIPRANKS
·
Mar 28

FibroBiologics files to sell 1.14M shares of common stock, warrants

TIPRANKS
·
Mar 28

FibroBiologics Cut to Hold From Buy by D. Boral Capital

Dow Jones
·
Mar 27

FibroBiologics announces 1-for-20 reverse stock split

TIPRANKS
·
Mar 26

BRIEF-Fibrobiologics Announces Reverse Stock Split To Regain Compliance With Nasdaq’S Bid Price Requirement

Reuters
·
Mar 26